OSCILLOCOCCINUM
Natural health product licensed in Canada
- Other names
- OSCILLO
- Licence holder
- Boiron Canada Inc.
- NPN or DIN-HM
- 80014156
- Status
- Active licence
- Licence date
- 21 October 2009
- Revision date
- 22 April 2014
- Form
- Globules
- Route of administration
- Orale
- Application type
- Homéopathique
If this product were sold in France
- Information
Homeopathic medicine in Canada, outside the scope of food supplements in France. Nutrient doses are not analysed.
Homéopathique. Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Anas barbariae hepatis et cordis extractum Source : Autolysat filtré de foie et c¿ur d'Anas Barbariae | 200 C | Not calculated |
Non-medicinal ingredients
Sucrose, Lactose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Nourrissons | maximum: 2 years | 1 Tube | Not specified |
| Adultes | Not specified | 1 Tube | Not specified |
| Enfants | minimum: 2 years | 1 Tube | Not specified |
Uses authorised in Canada
Médicament homéopathique pour le soulagement des états grippaux: Courbatures, maux de tête, fièvre, frissons. Réduit la durée des symptômes de la grippe.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Avis aux diabétiques: Ce produit contient 0,85g de sucrose et 0,15g de lactose par tube-dose granules.
Source
Official Health Canada record, licence 80014156
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2014. Photograph the packaging to check whether it has changed. Photograph the packaging